Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L LARSON

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|April 1, 1988
Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivityP S Portoghese, H Nagase, A W Lipkowski, et al.
Journal of Medicinal Chemistry|November 21, 1998
Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonistsG Subramanian, M G Paterlini, D L Larson, et al.
Physiological Zoology|November 3, 1998
Effects of the herbicide atrazine on Ambystoma tigrinum metamorphosis: duration, larval growth, and hormonal responseD L Larson, S McDonald, A J Fivizzani, et al.
Journal of Medicinal Chemistry|April 26, 2000
Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonistsD L Larson, R M Jones, S A Hjorth, et al.
Journal of Medicinal Chemistry|February 1, 1979
Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist propertiesP S Portoghese, D L Larson, J B Jiang, et al.
International Advances in Surgical Oncology|January 1, 1981
Prolatin secreting pituitary adenomasM E Leavens, N A Samaan, D L Larson, et al.
European Journal of Pharmacology|January 8, 1985
Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA)S J Ward, D S Fries, D L Larson, et al.
The Cleft Palate Journal|April 1, 1980
Nasal obstruction as a complication of pharyngeal flap surgeryJ B Thurston, D L Larson, J C Shanks, et al.
Journal of Medicinal Chemistry|September 1, 1983
Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labelsL M Sayre, D L Larson, D S Fries, et al.
Head & Neck|May 1, 1989
Lateral arm free flap in oral cavity reconstruction: a functional evaluationH S Matloub, D L Larson, J C Kuhn, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|April 1, 1988
Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivityP S Portoghese, H Nagase, A W Lipkowski, et al.
Journal of Medicinal Chemistry|November 21, 1998
Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonistsG Subramanian, M G Paterlini, D L Larson, et al.
Physiological Zoology|November 3, 1998
Effects of the herbicide atrazine on Ambystoma tigrinum metamorphosis: duration, larval growth, and hormonal responseD L Larson, S McDonald, A J Fivizzani, et al.
Journal of Medicinal Chemistry|April 26, 2000
Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonistsD L Larson, R M Jones, S A Hjorth, et al.
Journal of Medicinal Chemistry|February 1, 1979
Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist propertiesP S Portoghese, D L Larson, J B Jiang, et al.
International Advances in Surgical Oncology|January 1, 1981
Prolatin secreting pituitary adenomasM E Leavens, N A Samaan, D L Larson, et al.
European Journal of Pharmacology|January 8, 1985
Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA)S J Ward, D S Fries, D L Larson, et al.
The Cleft Palate Journal|April 1, 1980
Nasal obstruction as a complication of pharyngeal flap surgeryJ B Thurston, D L Larson, J C Shanks, et al.
Journal of Medicinal Chemistry|September 1, 1983
Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labelsL M Sayre, D L Larson, D S Fries, et al.
Head & Neck|May 1, 1989
Lateral arm free flap in oral cavity reconstruction: a functional evaluationH S Matloub, D L Larson, J C Kuhn, et al.
Pageof 13